CognitiveFDA Approved

Semax

Intranasal

Overview

A synthetic heptapeptide analog of the ACTH(4-7) fragment (Met-Glu-His-Phe-Pro-Gly-Pro) with nootropic and neuroprotective properties. Semax modulates BDNF and NGF expression, enhances monoaminergic neurotransmission, and provides neuroprotection through anti-oxidant and anti-inflammatory mechanisms.

Mechanism of Action

It crosses the blood-brain barrier via intranasal administration..

Research Summary & Key Findings

Approved in Russia and Ukraine for treatment of stroke, cognitive disorders, and optic nerve disease. Clinical studies demonstrated improved memory, attention, and cognitive performance. Research shows upregulation of BDNF and trkB expression in the hippocampus and cortex.

Clinical Status

FDA Approved

Semax has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.

Administration Routes

Intranasal

Related Peptides in Cognitive

Find a Provider

Find a verified provider who offers Semax therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Semax.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.